openPR Logo
Press release

The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson's disease treatment in the future

02-09-2019 12:12 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Parkinson's Disease Therapeutics Market

Parkinson's Disease Therapeutics Market

Parkinson's disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson's disease progression leads to uncontrolled body movement of the patient. There is no cure presently for Parkinson's disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson's disease mainly affects people over 50 and the risk increases with increasing age. Parkinson's disease treatment is used to control symptoms such as uncontrolled movement, shakiness of hands, and some others. The therapeutic approaches like levodopa in combination with carbidopa is considered as an effective treatment over symptoms of Parkinson's disease. The surgical treatment option is available but it is only effective for patients who are previously responded to levodopa therapy. The research and development in the field of Parkinson's disease therapeutic will help in the treatment of Parkinson's disease.

Request a FREE sample Report of Parkinson's disease therapeutics market at: https://www.coherentmarketinsights.com/insight/request-sample/494

Increase in prevalence of Parkinson's disease across the world is driving the Parkinson’s disease therapeutics market

According to Parkinson's disease foundation, more than 10 million people globally are living with Parkinson's disease and 60,000 Americans are diagnosed with Parkinson's disease each year. The rising prevalence of Parkinson's disease across the world is one of the major factor which is driving the Parkinson's disease therapeutic market. Rising male patients, is also the major factor owing to Parkinson's disease therapeutic market, because as mentioned in the data of Parkinson's disease foundation, chances of getting Parkinson's disease are one and half times more in men than women. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are some other causes which are likely to drive the Parkinson's disease therapeutic market. However some restraints like expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the cessation of Parkinson's disease therapeutic market.

Key players in the Parkinson's disease therapeutics market globally are:
-Salix Pharmaceuticals
-Teva Pharmaceutical Industries Ltd.
-Novartis AG
-GlaxoSmithKline Plc.
-Mylan N.V.
-Orion Corporation
-Boehringer Ingelheim
-UCB
-Impax Labs

The advancements in medical devices segment for Parkinson's disease treatment is expected to boost the growth in Parkinson's disease therapeutic market

Global Parkinson's disease therapeutic market is segmented on the basis of treatment type, end user and geographical regions

On the basis of treatment type:
-Medical Devices
-Deep Brain Stimulation (DBS) Devices
-Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
-Drug Class
-Dopamine precursors
-COMT Inhibitors
-MAO Inhibitors
-Peripheral Decarboxylase Inhibitors
-Others

On the basis of end user:
-Clinics
-Hospitals
-Homecare Settings

New advancements in the treatment of Parkinson's disease has helped to boost the growth in North America for Parkinson's disease therapeutic market.

Regional segmentation of Parkinson's disease therapeutic market according to coherent market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East, and Africa. High prevalence of Parkinson's disease and good reimbursement policies are some of factors which allows the North America region to dominate in the Parkinson's disease market. For instance, over 40 medicines are developed for the treatment of parkinsons disease and many have gained the fast track designation from U.S. Food and Drug Administration (FDA) in North America. North America is expected to hold the largest share in the Parkinson's disease market because of increase in investments in research and development for Parkinson's disease.

For More Details On this Report: https://www.coherentmarketinsights.com/ongoing-insight/parkinsons-disease-therapeutic-market-494

New product development is the key strategy adopted by major industry player in Parkinson's disease therapeutics market

Key players in the Parkinson's disease therapeutics market globally are Salix Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., Mylan N.V., Orion Corporation, Boehringer Ingelheim, UCB, and Impax Labs. Many of the key players involved in the anti-Parkinson's disease medication and some of the biopharmaceuticals research companies in the U.S. are currently in the development of new medicines for treatment of Parkinson's disease. The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson's disease treatment in the future.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson's disease treatment in the future here

News-ID: 1574461 • Views: 497

More Releases from Coherent Market Insights

Industrial Water Management Market To Rise Demand, Analysis By Revenue of Top Pl …
Industrial water management involves deployment of sustainable solutions for water and wastewater management in industries to ensure optimum utilization of fresh water sources and of water conservation. These solutions aid companies to reduce adverse environmental impacts, enhance their internal workflow processes with optimum costs, and adhere to stringent regional regulations. These solutions have environmental, social, and economic benefits and this is expected to aid the companies in the near future. Download
Sarcopenia Treatment Market In-depth Study 2019: GlaxoSmithKline, Radius Health …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Sarcopenia Treatment market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Sarcopenia Treatment market research report displays the latest industry insights with future trends and analysis
Testosterone Replacement Therapy Market Boosting Growth By Top Players AbbVie, I …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Testosterone Replacement Therapy market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Testosterone Replacement Therapy market research report displays the latest industry insights with future trends
Hepatitis C Drugs Market 2019 | Rapid Growth by Players Merck & Co. Inc., Vertex …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Hepatitis C Drugs market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Hepatitis C Drugs market research report displays the latest industry insights with future trends

All 5 Releases


More Releases for Parkinson

QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide
Slitter Market Analysis Report By Key Players- Kampf, Euromac, Parkinson Technol …
UpMarketResearch offers a latest published report on “Global Slitter Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 136 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Free Sample Report@ https://www.upmarketresearch.com/home/requested_sample/2980 The report begins with the overview of the Slitter market and updates
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE Become knowledgeable about the advancements in surgery The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and